NLV-III Investment Opportunity The objective of NLV-III is to invest in a portfolio of healthcare technology companies that offer attractive risk-adjusted returns. The companies that comprise the portfolio will be selected and managed by a team of highly experienced senior partners who have developed and proven their investment process over many years and multiple funds. The investment strategy for NLV-III is similar to the strategies pursued in prior funds, in that it will have a core focus on biopharmaceutical investments with a balance of investments across other healthcare technology sectors. Given the strength and stability of the team, the consistency and the depth of the track record, and the positive market forces and investment conditions that are expected to be in place during the life of the Fund, the Fund Managers believe NLV-III offers investors an opportunity for attractive returns. 10 CONTROL NUMBER 257 - CONFIDENTIAL HOUSE_OVERSIGHT_024021